Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...
Tag: Women's Health
Menopause Supplement Industry To Grow To $22.7 Billion By 2028 As Women Seek Out Alternative Treatments
“The industry consists of companies selling unvalidated, poorly formulated, over-hyped products … [+]s which offer few, if any benefits.” This is why LYMA, a supplement specialist brand, has lau...